✦ LIBER ✦

Comparison of two dosing regimens of gabexate mesilate (FOY® in the prevention of post-ercp pancreatitis: Results of a multicentre controlled trial

✍ Scribed by A. Mariani; L. Frulloni; E. Masci; S. Curioni; A. Tittobello; G. Cavallini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of two dosing regimens of gab

✍ Enzo Masci; Giorgio Cavallini; Alberto Mariani; Luca Frulloni; Pier Alberto Test 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 60 KB

Use of Nafamostat Mesilate and Gabexate

✍ Cheol Woong Choi; Dae Hwan Kang; Gwang-Ha Kim; Geun-Am Song; Jae-Sup Eum; Sang-Y 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Pre-Study protocol MagPEP: a multicentre

✍ Gabriele Fluhr, Julia Mayerle, Eckhard Weber, Ali Aghdassi… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 304 KB

Efficacy of postprocedure administration

✍ Gianpiero Manes; Sandro Ardizzone; Giovanni Lombardi; Generoso Uomo; Oreste Pier 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Low-dose heparin for the prevention of p

✍ O. Barkay; E. Niv; E. Santo; R. Bruck; A. Hallak; F. M. Konikoff 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 166 KB

Gabexate mesilate (FOY®) in the preventi

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 171 KB